Results from a new Phase 3 study conducted by the Celgene Corporation demonstrate that ozanimod, a drug candidate originally discovered and optimized at The Scripps Research Institute (TSRI), can reduce the frequency of multiple ...
Feb 21, 2017
0
2
A type of treatment for multiple sclerosis that 'resets' the immune system may stop progression of the disease in nearly half of patients.
Feb 20, 2017
0
3809
People who inherit genetic variants affecting the function of their immune system are at increased risk of developing the most common form of leukaemia, a major new study reveals.
Feb 6, 2017
0
89
Researchers from the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku, Finland, have studied over ten million DNA variations and found new links between the human genome and inflammation ...
Feb 1, 2017
0
2
A pair of studies by researchers at UC San Francisco suggest that genetic variants that have distinct effects on physical traits such as height, weight, body mass, and body shape in men versus women are also linked to men's ...
Jan 23, 2017
0
84
German lawmakers on Thursday legalised cannabis use for medical purposes for people with serious diseases such as certain cancers and multiple sclerosis.
Jan 19, 2017
0
0
While most of us haven't heard of astrocytes, these cells are four times as plentiful in the human brain as nerve cells. Now, a team led by researchers at the Stanford University School of Medicine has found that astrocytes, ...
Jan 18, 2017
0
107
The multiple sclerosis (MS) therapy alemtuzumab can trigger severe, unpredictable side effects. This was the finding by a team led by Prof Dr Aiden Haghikia and Prof Dr Ralf Gold from the Department of Neurology of the Ruhr-Universität ...
Jan 18, 2017
0
16
Dementia is more common in people who live within 50 metres of a major road than those who live further away, according to a study looking at 6.6 million people published in The Lancet. However, the study found no link between ...
Jan 5, 2017
1
60
In findings that show the effectiveness of a new strategy for treating multiple sclerosis (MS), researchers are reporting positive results from three large, international, multicenter Phase III clinical trials of the investigational ...
Dec 22, 2016
0
1097
